Healthcare
Global

Healthcare Experts

Nicole Urban

Research Professor
Health Services
Fred Hutchinson Cancer Rearch Center
United States of America

Biography

Nicole Urban is a Member of the Cancer Prevention Research Program of the Public Health Sciences Division and Program Head of the Gynecologocal Cancer Research Program at the Fred Hutchinson Cancer Research Center. She is also the Scientific Director of the Marsha Rivkin Center for Ovarian Cancer Research. For the past 10 years Dr. Urban has studied ways to improve the use, performance and efficacy of breast and ovarian cancer screening tools. She is particularly interested in the evaluation of markers detectable in serum for use in cancer screening. Education ScD   Harvard University, 1978   (Biostatistics, Health Services Admin) MS   Harvard University, 1973   (Biostatistics) BA   Simmons College, 1970   (English Literature)

Research Interest

Methods designed to improve the use, performance, and efficacy of breast and ovarian cancer screening tools, with particular emphasis on the discovery, development, and validation of markers for use in cancer risk assessment and screening.

Publications

  • Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, Schilsky RL, Shak S, Skates SJ, Urban N, Kramer BS, Khoury MJ, Ransohoff DF. Leveraging biospecimen resources for discovery or validation of markers for early cancer detection. J Natl Cancer Inst. 2015 Feb 16;107(4). pii: djv012. doi: 10.1093/jnci/djv012. Print 2015 Apr. PMID: 25688116

  • Schummer M, Thorpe J, Giraldez M, Bergan L, Tewari M, Urban N. Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer. PLoS One. 2015 Nov 13;10(11):e0142911. doi: 10.1371/journal.pone.0142911. eCollection 2015. PMID: 26565788 PMCID: PMC4643893

  • Buas MF, Gu H, Djukovic D, Zhu J, Drescher CW, Urban N, Raftery D, Li CI. Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors. Gynecol Oncol. 2015 Oct 30. pii: S0090-8258(15)30168-2. doi: 10.1016/j.ygyno.2015.10.021. [Epub ahead of print] PMID: 26521694 PMCID: PMC5310763

  • Andersen MR, Thorpe J, Buist DS, Beatty JD, Watabayashi K, Hanson N, Resta R, Chubak J, Urban N. Cancer risk awareness and concern among women with a family history of breast or ovarian cancer. Behav Med. 2014 Jul 25:0. [Epub ahead of print] PMID: 25062114 PMCID: PMC4469617

Global Experts from United States of America

Global Experts in Subject

Share This Profile